Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring the case for research on incorporating psychedelics within interventions for borderline personality disorder
Richard J. Zeifman, Anne Catherine Wagner
Journal of Contextual Behavioral Science (2019) Vol. 15, pp. 1-11
Closed Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

The Therapeutic Potential of Psilocybin
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
Molecules (2021) Vol. 26, Iss. 10, pp. 2948-2948
Open Access | Times Cited: 156
Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression
Roberta Murphy, Hannes Kettner, Rick Zeifman, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 147
Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance
Max Wolff, Ricarda Evens, Lea J. Mertens, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 141
Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis
Kwonmok Ko, Emma I Kopra, Anthony J. Cleare, et al.
Journal of Affective Disorders (2022) Vol. 322, pp. 194-204
Closed Access | Times Cited: 87
Case analysis of long-term negative psychological responses to psychedelics
Rebecka Bremler, Nancy Katati, Parvinder Shergill, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 46
Psychiatric risks for worsened mental health after psychedelic use
Alessia Marrocu, Hannes Kettner, Brandon Weiss, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 3, pp. 225-235
Open Access | Times Cited: 18
Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation
Richard J. Zeifman, Anne Catherine Wagner, Ros Watts, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 86
Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
Rita Kočárová, Jiřı́ Horáček, Robin Carhart‐Harris
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 68
Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry
Gregory Barber, Charles C. Dike
Psychiatric Services (2023) Vol. 74, Iss. 8, pp. 838-846
Closed Access | Times Cited: 38
Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder
Richard J. Zeifman, Hannes Kettner, Stephen Ross, et al.
European journal of psychotraumatology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)
Richard J. Zeifman, Meg J. Spriggs, Hannes Kettner, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial
Richard J. Zeifman, Nikhita Singhal, Rafael G. dos Santos, et al.
Psychopharmacology (2020) Vol. 238, Iss. 2, pp. 453-459
Closed Access | Times Cited: 61
Psychedelics and Psychotherapy
Sandeep M. Nayak, Matthew W. Johnson
Pharmacopsychiatry (2020) Vol. 54, Iss. 04, pp. 167-175
Closed Access | Times Cited: 54
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective
John R. Kelly, Claire M. Gillan, Jack Prenderville, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 51
On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review
Richard J. Zeifman, Nikhita Singhal, Leah Breslow, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 436-451
Open Access | Times Cited: 47
Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression
Brandon Weiss, Induni Ginige, Lu Shannon, et al.
Psychological Medicine (2023) Vol. 54, Iss. 1, pp. 178-192
Open Access | Times Cited: 21
Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences
Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Deep CANALs: a deep learning approach to refining the canalization theory of psychopathology
Arthur Juliani, Adam Safron, Ryota Kanai
Neuroscience of Consciousness (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 6
Prefrontal contributions to the stability and variability of thought and conscious experience
Andre Zamani, Robin Carhart‐Harris, Kalina Christoff
Neuropsychopharmacology (2021) Vol. 47, Iss. 1, pp. 329-348
Open Access | Times Cited: 34
The Emerging Field of Psychedelic Psychotherapy
Gregory Barber, Scott T. Aaronson
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 583-590
Open Access | Times Cited: 28
Psilocybin for Trauma-Related Disorders
Amanda Khan, Ellen Bradley, Aoife O’Donovan, et al.
Current topics in behavioral neurosciences (2022), pp. 319-332
Closed Access | Times Cited: 25
Novel Treatment Approaches for Substance Use Disorders: Therapeutic Use of Psychedelics and the Role of Psychotherapy
Michael Koslowski, Matthew W. Johnson, Gerhard Gründer, et al.
Current Addiction Reports (2021) Vol. 9, Iss. 1, pp. 48-58
Open Access | Times Cited: 32
Mindfulness: Unpacking its three shades and illuminating integrative ways to understand the construct
Carole Daniel, Isabelle Walsh, Jessica Mesmer‐Magnus
International Journal of Management Reviews (2022) Vol. 24, Iss. 4, pp. 654-683
Closed Access | Times Cited: 22
Could Psychedelics be useful in the Treatment of Patients with Personality Disorder? A Case Report of Psychotherapy with Concomitant Use of Psychedelics
Martin Blay, Inès Benmakhlouf, Mario Speranza
Psychiatry Research Case Reports (2025), pp. 100245-100245
Open Access
Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach
Armando Albert, Anthony L. Back
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top